U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C19H35ClN2O5S
Molecular Weight 439.01
Optical Activity UNSPECIFIED
Defined Stereocenters 9 / 9
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MIRINCAMYCIN

SMILES

[H][C@@]1(O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O)[C@H](NC(=O)[C@@H]2C[C@@H](CCCCC)CN2)[C@H](C)Cl

InChI

InChIKey=UFFIWDQGZCWMIU-YLKLGEPYSA-N
InChI=1S/C19H35ClN2O5S/c1-4-5-6-7-11-8-12(21-9-11)18(26)22-13(10(2)20)17-15(24)14(23)16(25)19(27-17)28-3/h10-17,19,21,23-25H,4-9H2,1-3H3,(H,22,26)/t10-,11+,12-,13+,14-,15+,16+,17+,19+/m0/s1

HIDE SMILES / InChI

Molecular Formula C19H35ClN2O5S
Molecular Weight 439.01
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 9 / 9
E/Z Centers 0
Optical Activity UNSPECIFIED

Mirincamycin, a protein biosynthesis inhibitor was studied as an antibacterial agent. It was shown that mirincamycin could be promising candidate in the therapy and prophylaxis of multidrug-resistant falciparum malaria. Moreover, in combination with 4 or 8-aminoquinolines it could be used for the treatment and relapse prevention of vivax malaria. In addition, was studied the anti-relapse activity of mirincamycin in the Plasmodium cynomolgi sporozoite-infected Rhesus monkey model. However, the negative P. cynomolgi hypnozoite data indicates that mirincamycin is unlikely to have potential as a clinical anti-relapse agent.

Approval Year

PubMed

PubMed

TitleDatePubMed
In vitro activity of mirincamycin (U24729A) against Plasmodium falciparum isolates from Gabon.
2010 Jan
Absolute bioavailability of cis-mirincamycin and trans-mirincamycin in healthy rhesus monkeys and ex vivo antimalarial activity against Plasmodium falciparum.
2011 Dec
Substance Class Chemical
Created
by admin
on Fri Dec 15 18:22:48 GMT 2023
Edited
by admin
on Fri Dec 15 18:22:48 GMT 2023
Record UNII
F6T0FI8XCS
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MIRINCAMYCIN
INN  
INN  
Official Name English
1'-DEMETHYL-4'-DEPROPYL-4'-PENTYLCLINDAMYCIN
Common Name English
L-THREO-,ALPHA.-D-GALACTO-OCTOPYRANOSIDE, METHYL 7-CHLORO-6,7,8-TRIDEOXY-6-(((4-PENTYL-2-PYRROLIDINYL)CARBONYL)AMINO)-1-THIO-
Common Name English
7-CHLORO-N-DEMETHYL-4'-PENTYLLINCOMYCIN
Common Name English
mirincamycin [INN]
Common Name English
Code System Code Type Description
ChEMBL
CHEMBL2110945
Created by admin on Fri Dec 15 18:22:48 GMT 2023 , Edited by admin on Fri Dec 15 18:22:48 GMT 2023
PRIMARY
NCI_THESAURUS
C170184
Created by admin on Fri Dec 15 18:22:48 GMT 2023 , Edited by admin on Fri Dec 15 18:22:48 GMT 2023
PRIMARY
PUBCHEM
76960025
Created by admin on Fri Dec 15 18:22:48 GMT 2023 , Edited by admin on Fri Dec 15 18:22:48 GMT 2023
PRIMARY
CAS
19096-41-4
Created by admin on Fri Dec 15 18:22:48 GMT 2023 , Edited by admin on Fri Dec 15 18:22:48 GMT 2023
ALTERNATIVE
MESH
C000867
Created by admin on Fri Dec 15 18:22:48 GMT 2023 , Edited by admin on Fri Dec 15 18:22:48 GMT 2023
PRIMARY
EPA CompTox
DTXSID301043385
Created by admin on Fri Dec 15 18:22:48 GMT 2023 , Edited by admin on Fri Dec 15 18:22:48 GMT 2023
PRIMARY
SMS_ID
100000080645
Created by admin on Fri Dec 15 18:22:48 GMT 2023 , Edited by admin on Fri Dec 15 18:22:48 GMT 2023
PRIMARY
CAS
31101-25-4
Created by admin on Fri Dec 15 18:22:48 GMT 2023 , Edited by admin on Fri Dec 15 18:22:48 GMT 2023
PRIMARY
EVMPD
SUB08990MIG
Created by admin on Fri Dec 15 18:22:48 GMT 2023 , Edited by admin on Fri Dec 15 18:22:48 GMT 2023
PRIMARY
INN
3558
Created by admin on Fri Dec 15 18:22:48 GMT 2023 , Edited by admin on Fri Dec 15 18:22:48 GMT 2023
PRIMARY
FDA UNII
F6T0FI8XCS
Created by admin on Fri Dec 15 18:22:48 GMT 2023 , Edited by admin on Fri Dec 15 18:22:48 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY